Found 1085 matching trials
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer PHASE2 Persons diagnosed with thyroid cancer are often treated initially with a th...
Show More Location
University of California, San Francisco
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery PHASE3 This randomized phase III trial studies how well pazopanib hydrochloride wo...
Show More Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Learn More & Join Trial
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis PHASE2 The purpose of this study is to assess whether NaF PET/CT scans can be used...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Techniques NA Prostate and breast cancer continues to be the most common cancer among men...
Show More Location
Turku University Hospital
Learn More & Join Trial
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease EARLY_PHASE1 This study is a prospective, case-control study evaluating whether the PET ...
Show More Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine PHASE2 This phase II trial is studying how well romidepsin works in treating patie...
Show More Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia PHASE1 This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial